Colorado BioScience Association
Colorado BioScience Association

Colorado’s Bioscience Industry Awarded Over $23 Million in Funding from Federal Qualifying Therapeutic Discovery Project Grant and Tax Credit Program

According to the Colorado BioScience Association (CBSA), Colorado’s bioscience industry received more than $23 million for 102 different projects in the Qualifying Therapeutic Discovery Project (QTDP) program, per data posted online Monday by the Internal Revenue Service (IRS), in conjunction with the Department of Health and Human Services (HHS). Colorado ranks in the top ten of states applying for credits and grants under the new program.

Denver, CO, November 06, 2010 --(PR.com)-- Colorado’s bioscience industry received over $23 million for 102 different projects in the Qualifying Therapeutic Discovery Project (QTDP) program, per data posted online November 1 by the Internal Revenue Service (IRS), in conjunction with the Department of Health and Human Services (HHS). The announcement is made by Holli Baumunk, President & CEO of the Colorado BioScience Association (CBSA), who is proud to say that Colorado ranks in the top ten of all states applying for credits and grants under the new program.

“The QTDP program was created under the Patient Protection and Affordable Care Act of 2010 which was enacted in March of this year,” Baumunk explains. “This was a unique program in which $1 billion was allocated for tax credits and grants for start-up companies in the bioscience industry to help encourage innovation, advance technology and help ensure that the U.S. remains competitive in this industry."

This new program was designed to provide tax credits and grants to small bioscience firms that show significant potential to produce cost saving therapies, support US jobs and increase US competitiveness.

More information about the QTDP program: http://www.irs.gov/businesses/small/article/0,,id=228690,00.html.

The following Colorado companies received QTDP tax credits and grants for their bioscience projects:

* Accelr8 Technology Corporation - accelr8.com
* Actium Biosystems, LLC - actiumbio.com
* Aktiv-Dry, LLC – aktiv-dry.com
* Allos Therapeutics, Inc. - received funding for six projects - allos.com
* ApopLogic, Inc. – received funding for two projects - apoplogic.com
* Aqueous Biomedical, Inc.- aqueousbio.com
* ARCA Biopharma, Inc. – received funding for two projects - arcabiopharma.com
* ArcScan, Inc. - arcscan.com
* AspenBio Pharma, Inc. - aspenbioinc.com
* Beacon Biotechnology, LLC - beaconbiotechnology.com
* BioAMPS International, Inc. - bioamps.com
* Biodesix, Inc. – received funding for six projects - biodesix.com
* BiOptix Diagnostics, Inc. - bioptix.com
* Bolder Biotechnology, Inc. – received funding for five projects - bolderbio.com
* Cell Point - cellpointweb.com
* CeMines, Inc. - cemines.com
* Cerapedics, Inc. – received funding for three projects - cerapedics.com
* CereScan Corp. – cerescanimaging.com
* Chata Biosystems, Inc. - chatasolutions.com
* Clovis Oncology, Inc. – received funding for two projects - clovisoncology.com
* Corgenix Medical Corp. - corgenix.com
* Crestone Inc. – received funding for two projects - crestonesystems.com
* EndoShape, Inc. – received funding for two projects - endoshape.com
* Eveia Medical, Inc. – eveiamedical.com
* Fertility Laboratories of Colorado, Inc. – flcolo.com
* Generations Medical Partners, LLC
* GlobeImmune, Inc. – received funding for three projects - globeimmune.com
* Greffex, Inc. - greffex.com
* Hiberna Corporation
* ICVRX, LLC
* Inviragen, Inc. – received funding for two projects - inviragen.com
* Isogenis, Inc. - isogenis.com
* Kestrel Labs, Inc. - kestrellabs.com
* Lanx, Inc. - lanx.com
* Leap Frogg, LLC
* MBC Pharma, Inc. - mbcpharma.com
* Micro-Imaging Solutions, LLC - micro-imaging.us
* MicroPhage, Inc. – received funding for two projects - microphage.com
* Miragen Therapeutics, Inc. - miragentherapeutics.com
* Myocept, Inc. - myocept.com
* N30 Pharmaceuticals, LLC - n30pharma.com
* Ocutronics, LLC - ocutronics.com
* Otologics, LLC - otologics.com
* Parascript, LLC - parascript.com
* PARE Surgical, Inc. - paresurgical.com
* Pathogen Systems, Inc. - crystaldiagnostics.com
* PharmaJet, Inc. - pharmajet.com
* Precision Photonics Corp. - precisionphotonics.com
* ProFoldRx, Inc. dba BaroFold, Inc. - barofold.com
* Protectstyle Corp.
* Pyxant Labs, Inc. – received funding for two projects - pyxant.com
* Rocky Mountain Biosystems, Inc. - received funding for two projects
* SomaLogic, Inc. – received funding for eight projects - somalogic.com
* Sophono Inc. - sophono.com
* Source Precision Medicine Inc. dba Source MDx - received funding for two projects - sourcemdx.com
* St Cardio Technologies - stcardio.com
* St. Renatus, LLC - st-renatus.com
* Sundance Diagnostics, Inc. - sundancedx.com
* Surefire Medical, Inc. - surefiremedical.com
* ValveXchange, Inc. - valvexchange.com
* Ventria Bioscience - received funding for three projects - ventria.com
* Vitrolife, Inc. - vitrolife.com

Link to the related HHS release, "Secretaries Geithner, Sebelius, NIH Director Collins Announce Recipients of Affordable Care Act Grants to Support Groundbreaking Biomedical Research," disseminated November 3: http://www.hhs.gov/news/press/2010pres/11/20101103b.html.

About the Colorado Bioscience Association

The CBSA is a not-for-profit corporation providing services and support for Colorado's growing biosciences industry. With more than 400 members, CBSA actively works to promote the growth of the industry by working for a better business environment, grow the state's biotech workforce, fight for policies that support a strong bioscience industry in the state and speak with a single voice on behalf of the industry. For more information, visit http://www.cobioscience.com.

CBSA also is found on these social media sites:

Twitter: @COBioscience
LinkedIn Group: http://www.linkedin.com/groups?about=&gid=98468&trk=anet_ug_grppro
Facebook Fan Page: http://www.facebook.com/ColoradoBioScienceAssociation
News Feed: http://coloradobio.blogspot.com
YouTube Channel: http://www.youtube.com/COBioscience

Contacts:

Leah Kientz, Director of Public Policy and Programs, Colorado BioScience Association –303-592-4088, lkientz@cobioscience.com

Maggie Chamberlin Holben, APR, Absolutely PR – http://www.absolutelypr.com – 303-984-9801, maggie@absolutelypr.com

###
Contact
Colorado BioScience Association
Maggie Holben
303-984-9801
http://www.cobioscience.com
ContactContact
Categories